M-d D. Levin

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma.

Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma.

Journal: British journal of haematology
Published: August 06, 2025

Treatment-Free Remission Outcomes in a BCR::ABL1 Digital PCR Selected Clinical Cohort of CML Patients.

Treatment-Free Remission Outcomes in a BCR::ABL1 Digital PCR Selected Clinical Cohort of CML Patients.

Journal: European journal of haematology
Published: August 25, 2024

The association between hospital volume and overall survival in adult AML patients treated with intensive chemotherapy.

The association between hospital volume and overall survival in adult AML patients treated with intensive chemotherapy.

Journal: ESMO open
Published: June 28, 2024

Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trial.

Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trial.

Journal: European journal of cancer (Oxford, England : 1990)
Published: February 02, 2024

Early-stage measurable residual disease dynamics and IGHV repertoire reconstitution during venetoclax and obinutuzumab treatment in chronic lymphocytic leukemia.

Early-stage measurable residual disease dynamics and IGHV repertoire reconstitution during venetoclax and obinutuzumab treatment in chronic lymphocytic leukemia.

Journal: Blood cancer journal
Published: March 02, 2023

Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis.

Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis.

Journal: Leukemia
Published: November 29, 2022

Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21R110.

Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21R110.

Journal: Leukemia
Published: March 18, 2022

Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?

Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?

Journal: Breast cancer research and treatment
Published: September 14, 2020

A new diagnostic work-up for defining anemia etiologies: a cohort study in patients ≥ 50 years in general practices.

A new diagnostic work-up for defining anemia etiologies: a cohort study in patients ≥ 50 years in general practices.

Journal: BMC family practice
Published: April 13, 2020

Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice.

Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice.

Journal: Breast (Edinburgh, Scotland)
Published: October 11, 2019

Digital microscopy as a screening tool for the diagnosis of hereditary hemolytic anemia.

Digital microscopy as a screening tool for the diagnosis of hereditary hemolytic anemia.

Journal: International journal of laboratory hematology
Published: July 11, 2017

Microbiological outcomes and antibiotic overuse in Emergency Department patients with suspected sepsis.

Microbiological outcomes and antibiotic overuse in Emergency Department patients with suspected sepsis.

Journal: The Netherlands journal of medicine
Published: June 28, 2017
Showing 1-12 of 15

Last Updated: 09/26/2026